Arthritis Pain Treatment:
Arthritis pain relief, news on Arthritis Treatment, Rheumatoid Arthritis articles and symptoms.
-
Jul 23rd, 2008
Updated rules add new arthritis drugs and combinations for treatment. However, these recommendations for rheumatoid arthritis treatment are not meant to override individualized care.
-
Jul 2nd, 2008
Health Canada is advising consumers not to use 3rd Generation In Homoeopathy Arthrit Indica Tablet due to concerns about possible side-effects.
-
Jul 1st, 2008
Researchers have found that a gene region known to play a role in some varieties of adult rheumatoid arthritis is also present in all types of childhood arthritis. The researchers say the responsible gene may be a "master switch" that helps turn on the debilitating disease.
-
Jun 17th, 2008
Travel Advantage Network raised more than $2,000, placing third in Anne Arundel County's Arthritis Walk 2008.
-
Jun 16th, 2008
Seven-year rheumatoid arthritis data from open-label extension studies show that treatment with Abbott's HUMIRA resulted in clinical remission among long-standing RA patients when used in combination with methotrexate.
-
Jun 16th, 2008
Patients who suffer the chronic and debilitating effects of rheumatoid arthritis achieved significant improvements in signs and symptoms when treated with Roche's ACTEMRA alone or in combination with methotrexate compared with methotrexate alone.
-
Jun 14th, 2008
New data suggest that patients with osteoarthritis pain of the knee treated with 60 mg and 120 mg Cymbalta once daily experienced significant pain reduction.
-
Jun 13th, 2008
Patients receiving every four-week subcutaneous injections of golimumab 50 mg and 100 mg and weekly methotrexate experienced significant improvements in the signs and symptoms of rheumatoid arthritis.
-
Jun 13th, 2008
Patients with moderately-to-severely active rheumatoid arthritis who were previously treated with anti-tumor necrosis factor-alpha agents, experienced significant improvements in signs and symptoms and physical function after receiving every four-week subcutaneous injections of golimumab.
-
Jun 5th, 2008
We have too few pediatric rheumatologists in the United States, but this is not the only problem in the delay or inacurrate diagnosis of juvenile rheumatoild arthritis (JRA).
